• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发肿瘤血管侵犯而非淋巴管侵犯对乳腺癌患者预后的影响。

Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer.

机构信息

FACS, Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-machi, Maebashi, Gunma 371-8511, Japan.

出版信息

Anticancer Res. 2014 Mar;34(3):1255-9.

PMID:24596369
Abstract

BACKGROUND

The prognostic value of lymphovascular invasion (LVI) in patients with breast cancer is unclear. Lymphatic invasion may mainly represent the selective affinity of breast cancer cells for lymph nodes. This study was undertaken to evaluate the presence of vascular invasion that may reflect systemic disease as a predictor of disease recurrence in breast cancer, separate from lymphatic invasion of the primary tumor.

PATIENTS AND METHODS

We retrospectively evaluated the cases of 263 consecutive female patients with primary breast cancer who underwent a radical breast operation. We examined the relationship between recurrence and the prognostic significance of clinico-pathological factors, particularly lymphatic (Iy) and vascular invasion (v).

RESULTS

The presence of lymphatic invasion and that of vascular invasion were significant in univariate analysis. The presence of vascular invasion was an independent prognostic factor, but lymphatic invasion lost its prognostic significance in multivariate analysis. Among the 91 patients in the ly-/v- group, 5 (5.5%) had disease recurrence, and among the 73 patients in the ly+/v- group, 5 (6.8%) had disease recurrence. On the other hand, among the 95 patients in the ly+/v+ group, 19 (20.0%) had a recurrence, and among the 3 patients in the ly-/v+ group, one had a recurrence. It is interesting to note that despite the presence of lymphatic invasion, the group without vascular invasion (ly+/v-) had a few patients with distant metastases, a result which is similar to that of the ly-/v- group.

CONCLUSION

The presence of vascular invasion, but not lymphatic invasion, could be an indicator of high biological aggressiveness and may be a valid prognostic factor for breast cancer.

摘要

背景

乳腺癌中淋巴管浸润(LVI)的预后价值尚不清楚。淋巴浸润可能主要代表乳腺癌细胞对淋巴结的选择性亲和力。本研究旨在评估血管浸润的存在,血管浸润可能反映全身性疾病,是乳腺癌复发的预测因素,与原发性肿瘤的淋巴浸润分开。

患者和方法

我们回顾性评估了 263 例接受根治性乳房手术的原发性乳腺癌女性患者的病例。我们检查了复发与临床病理因素(特别是淋巴(Iy)和血管浸润(v))预后意义之间的关系。

结果

在单因素分析中,存在淋巴浸润和血管浸润具有显著意义。血管浸润的存在是独立的预后因素,但在多因素分析中,淋巴浸润失去了其预后意义。在 ly-/v-组的 91 例患者中,有 5 例(5.5%)发生疾病复发,在 ly+/v-组的 73 例患者中,有 5 例(6.8%)发生疾病复发。另一方面,在 ly+/v+组的 95 例患者中,有 19 例(20.0%)出现复发,在 ly-/v+组的 3 例患者中,有 1 例出现复发。有趣的是,尽管存在淋巴浸润,但没有血管浸润的组(ly+/v-)有少数患者发生远处转移,这一结果与 ly-/v-组相似。

结论

血管浸润的存在,而不是淋巴浸润的存在,可能是高生物学侵袭性的指标,并且可能是乳腺癌的有效预后因素。

相似文献

1
Impact of the prognostic value of vascular invasion, but not lymphatic invasion, of the primary tumor in patients with breast cancer.原发肿瘤血管侵犯而非淋巴管侵犯对乳腺癌患者预后的影响。
Anticancer Res. 2014 Mar;34(3):1255-9.
2
Vascular invasion, but not lymphatic invasion, of the primary tumor is a strong prognostic factor in patients with colorectal cancer.原发性肿瘤的血管侵犯,但无淋巴管侵犯,是结直肠癌患者的一个强有力的预后因素。
Anticancer Res. 2014 Jun;34(6):3147-51.
3
Impact of vascular invasion of a primary tumor as a strong risk factor for disease recurrence in patients with node-positive breast cancer.原发性肿瘤血管侵犯作为淋巴结阳性乳腺癌患者疾病复发的强风险因素的影响。
Am Surg. 2015 May;81(5):523-6.
4
Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.改进的淋巴管浸润检测方法表明,它是乳腺癌血管浸润的主要方式,且具有重要的临床意义。
Am J Surg Pathol. 2007 Dec;31(12):1825-33. doi: 10.1097/PAS.0b013e31806841f6.
5
The role of lymph node metastasis in the systemic dissemination of breast cancer.淋巴结转移在乳腺癌系统播散中的作用。
Ann Surg Oncol. 2009 Dec;16(12):3396-405. doi: 10.1245/s10434-009-0659-2.
6
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.淋巴管浸润是前列腺腺癌的一个独立预后因素。
J Urol. 2005 Dec;174(6):2181-5. doi: 10.1097/01.ju.0000181215.41607.c3.
7
Prognostic value of extracapsular invasion of axillary lymph nodes combined with peritumoral vascular invasion in patients with breast cancer.乳腺癌患者腋窝淋巴结包膜外侵犯联合瘤周血管侵犯的预后价值
Ann Surg Oncol. 2015 Jan;22(1):52-8. doi: 10.1245/s10434-014-3941-x. Epub 2014 Jul 25.
8
Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.淋巴管内皮免疫染色诊断的淋巴管侵犯在乳腺癌患者中的预后意义
Oncol Rep. 2007 May;17(5):997-1003.
9
Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.淋巴管浸润是子宫内膜癌淋巴结转移的预测因素,也是一个重要的预后因素。
Int J Clin Oncol. 2018 Jun;23(3):532-538. doi: 10.1007/s10147-017-1227-6. Epub 2017 Dec 23.
10
Prognostic value of extracapsular extension of axillary lymph node metastases in T1 to T3 breast cancer.T1至T3期乳腺癌腋窝淋巴结转移的包膜外扩展的预后价值
Ann Surg Oncol. 2005 Mar;12(3):246-53. doi: 10.1245/ASO.2005.02.029. Epub 2005 Mar 3.

引用本文的文献

1
Feline Mammary Tumors: A Comprehensive Review of Histological Classification Schemes, Grading Systems, and Prognostic Factors.猫乳腺肿瘤:组织学分类方案、分级系统和预后因素的综合综述
Vet Sci. 2025 Aug 5;12(8):736. doi: 10.3390/vetsci12080736.
2
Risk factors for early recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study in Japan (WJOG15721B).激素受体阳性、HER2阴性乳腺癌患者早期复发的危险因素:日本的一项回顾性队列研究(WJOG15721B)
Breast Cancer. 2025 Apr 10. doi: 10.1007/s12282-025-01700-y.
3
A nomogram model for predicting the risk of axillary lymph node metastasis in patients with early breast cancer and cN0 status.
用于预测早期乳腺癌且cN0状态患者腋窝淋巴结转移风险的列线图模型。
Oncol Lett. 2024 May 30;28(2):345. doi: 10.3892/ol.2024.14478. eCollection 2024 Aug.
4
The Ongoing Necessity of Sentinel Lymph Node Biopsy for cT1-2N0 Breast Cancer Patients.cT1-2N0期乳腺癌患者前哨淋巴结活检的持续必要性
Breast Care (Basel). 2023 Dec;18(6):473-482. doi: 10.1159/000532081. Epub 2023 Aug 17.
5
Quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging to predict lymphovascular invasion and survival outcome in breast cancer.动态对比增强磁共振成像定量参数预测乳腺癌淋巴管血管侵犯及生存预后。
Cancer Imaging. 2022 Oct 22;22(1):61. doi: 10.1186/s40644-022-00499-7.
6
Advances on the roles of tenascin-C in cancer.层粘连蛋白 C 在癌症中的作用研究进展。
J Cell Sci. 2022 Sep 15;135(18). doi: 10.1242/jcs.260244. Epub 2022 Sep 14.
7
Lymphatic Endothelial Markers and Tumor Lymphangiogenesis Assessment in Human Breast Cancer.人类乳腺癌中的淋巴管内皮标志物与肿瘤淋巴管生成评估
Diagnostics (Basel). 2021 Dec 21;12(1):4. doi: 10.3390/diagnostics12010004.
8
Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy.将抗抑郁药物与替沃扎尼联合进行直观重定位:乳腺癌治疗的精准医学。
Mol Cell Biochem. 2021 Nov;476(11):4177-4189. doi: 10.1007/s11010-021-04230-1. Epub 2021 Jul 29.
9
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers.人类乳腺癌、结直肠癌、肺癌、卵巢癌和前列腺癌中的肿瘤相关巨噬细胞
Front Oncol. 2020 Oct 22;10:566511. doi: 10.3389/fonc.2020.566511. eCollection 2020.
10
High FUT3 expression is a marker of lower overall survival of breast cancer patients.高 FUT3 表达是乳腺癌患者总生存较低的标志物。
Glycoconj J. 2020 Apr;37(2):263-275. doi: 10.1007/s10719-020-09914-2. Epub 2020 Feb 15.